F Scavonetto1, T Y Yeoh2, E C Umbreit3, T N Weingarten1, M T Gettman3, I Frank3, S A Boorjian3, R J Karnes3, D R Schroeder4, L J Rangel4, A C Hanson4, R E Hofer1, D I Sessler5, J Sprung6. 1. Department of Anesthesiology. 2. Department of Anesthesiology, Department of Anesthesia, National University Hospital, National University Health System, Singapore, Singapore. 3. Department of Urology, and. 4. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 5. Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA. 6. Department of Anesthesiology, sprung.juraj@mayo.edu.
Abstract
BACKGROUND: Systemic opioids are immunosuppressive, which could promote tumour recurrence. We, therefore, test the hypothesis that supplementing general anaesthesia with neuraxial analgesia improves long-term oncological outcomes in patients having radical prostatectomy for adenocarcinoma. METHODS: Patients who had general anaesthesia with neuraxial analgesia (n=1642) were matched 1:1 based on age, surgical year, pathological stage, Gleason scores, and presence of lymph node disease with those who had general anaesthesia only. Medical records were reviewed. Outcomes of interest were systemic cancer progression, recurrence, prostate cancer mortality, and all-cause mortality. Data were analysed using stratified proportional hazards regression, the Kaplan-Meier method, and log-rank tests. The median follow-up was 9 yr. RESULTS: After adjusting for comorbidities, positive surgical margins, and adjuvant hormonal and radiation therapies within 90 postoperative days, general anaesthesia only was associated with increased risk for systemic progression [hazard ratio (HR)=2.81, 95% confidence interval (CI) 1.31-6.05; P=0.008] and higher overall mortality (HR=1.32, 95% CI 1.00-1.74; P=0.047). Although not statistically significant, similar findings were observed for the outcome of prostate cancer deaths (adjusted HR=2.2, 95% CI 0.88-5.60; P=0.091). CONCLUSIONS: This large retrospective analysis suggests a possible beneficial effect of regional anaesthetic techniques on oncological outcomes after prostate surgery for cancer; however, these findings need to be confirmed (or refuted) in randomized trials.
BACKGROUND: Systemic opioids are immunosuppressive, which could promote tumour recurrence. We, therefore, test the hypothesis that supplementing general anaesthesia with neuraxial analgesia improves long-term oncological outcomes in patients having radical prostatectomy for adenocarcinoma. METHODS:Patients who had general anaesthesia with neuraxial analgesia (n=1642) were matched 1:1 based on age, surgical year, pathological stage, Gleason scores, and presence of lymph node disease with those who had general anaesthesia only. Medical records were reviewed. Outcomes of interest were systemic cancer progression, recurrence, prostate cancer mortality, and all-cause mortality. Data were analysed using stratified proportional hazards regression, the Kaplan-Meier method, and log-rank tests. The median follow-up was 9 yr. RESULTS: After adjusting for comorbidities, positive surgical margins, and adjuvant hormonal and radiation therapies within 90 postoperative days, general anaesthesia only was associated with increased risk for systemic progression [hazard ratio (HR)=2.81, 95% confidence interval (CI) 1.31-6.05; P=0.008] and higher overall mortality (HR=1.32, 95% CI 1.00-1.74; P=0.047). Although not statistically significant, similar findings were observed for the outcome of prostate cancer deaths (adjusted HR=2.2, 95% CI 0.88-5.60; P=0.091). CONCLUSIONS: This large retrospective analysis suggests a possible beneficial effect of regional anaesthetic techniques on oncological outcomes after prostate surgery for cancer; however, these findings need to be confirmed (or refuted) in randomized trials.
Authors: Gerald W Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino Journal: J Urol Date: 2002-02 Impact factor: 7.450
Authors: Tobias Piegeler; E Gina Votta-Velis; Guoquan Liu; Aaron T Place; David E Schwartz; Beatrice Beck-Schimmer; Richard D Minshall; Alain Borgeat Journal: Anesthesiology Date: 2012-09 Impact factor: 7.892
Authors: Kenneth S Tseng; Sachin Kulkarni; Elizabeth B Humphreys; H Ballentine Carter; Jacek L Mostwin; Alan W Partin; Misop Han; Christopher L Wu Journal: Reg Anesth Pain Med Date: 2014 Jul-Aug Impact factor: 6.288
Authors: Jill H Tseng; Renee A Cowan; Anoushka M Afonso; Qin Zhou; Alexia Iasonos; Narisha Ali; Errika Thompson; Yukio Sonoda; Roisin E O'Cearbhaill; Dennis S Chi; Nadeem R Abu-Rustum; Kara Long Roche Journal: Gynecol Oncol Date: 2018-09-02 Impact factor: 5.482
Authors: Joseph R Scarpa; Renzo G DiNatale; Roy Mano; Andrew W Silagy; Fengshen Kuo; Takeshi Irie; Patrick J McCormick; Gregory W Fischer; A Ari Hakimi; Joshua S Mincer Journal: Cancer Res Date: 2020-12-14 Impact factor: 13.312
Authors: Linda Ma Pak; Simon Haroutounian; William G Hawkins; Lori Worley; Monika Kurtz; Karen Frey; Menelaos Karanikolas; Robert A Swarm; Michael M Bottros Journal: BMJ Open Date: 2018-01-26 Impact factor: 2.692